Santhera Pharmaceuticals Holding AG (SPHDF)
OTC
Closed
Oct 14, 2026
Day's Range
18.3052 wk Range
12.28Overview - SPHDF - Santhera Pharmaceuticals Holding AG
Key Statistics
Valuation
Enterprise Value
329.05M
P/E (Trailing)
‪2.52‬
Price / Sales (TTM)
‪2.76‬
EV / EBITDA
‪-75.35‬
Profitability
Gross Margin
‪86.33%‬
Profit Margin
‪-31.45%‬
Operating Margin
‪-13.58%‬
Return on Assets
‪-3.92%‬
Return on Equity
‪416.68%‬
Ownership
Shares Outstanding
13.39M
Float
12.63M
Held by Insiders
‪11.15%‬
Held by Institutions
‪15.93%‬
Price stats
Beta
‪-0.39‬
50-Day Avg
‪21.25‬
200-Day Avg
‪20.56‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SPHDF - Santhera Pharmaceuticals Holding AG
Peers - SPHDF - Santhera Pharmaceuticals Holding AG
Peer Comparison
Compared with companies in Biotechnology listed on OTC.
Profile Summary - SPHDF - Santhera Pharmaceuticals Holding AG
About
Santhera Pharmaceuticals Holding AG is a Swiss specialty pharmaceutical company headquartered in Pratteln, Switzerland, dedicated to the research, development, and commercialization of innovative medicines for patients with rare and debilitating diseases. The company primarily targets unmet medical needs in…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
